We are live on ! Find out more
AHG

Akso Health Group
AHG

7 hedge funds and large institutions have $1.28M invested in Akso Health Group in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less capital invested

Capital invested by funds: $1.48M → $1.28M (-$205K)

22% less funds holding

Funds holding: 9 → 7 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$58.5K
2
VF
Virtu Financial
New York
+$18.5K
3
Jane Street
Jane Street
New York
+$16.9K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$164K
2
Two Sigma Investments
Two Sigma Investments
New York
-$95.4K
3
DTL
Dynamic Technology Lab
Singapore
-$23K
4
XT
XTX Topco
Cayman Islands
-$17K
5
Marshall Wace
Marshall Wace
United Kingdom
-$14K

AHG Hedge Fund Activity: Q1 2022 in Review

7 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q1 2022, worth a combined $1.28M — down 14% from $1.48M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of AHG and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $58.5K. The largest seller was Renaissance Technologies, cutting an estimated $164K.

  • 7 institutional investors held Akso Health Group (AHG) as of Q1 2022, down from 9 in Q4 2021.
  • Funds reported $1.28M of Akso Health Group stock for Q1 2022, down 14% quarter-over-quarter.
  • 3 funds opened new Akso Health Group positions in Q1 2022 and 5 closed out, a net change of -2 holders.
  • The largest Akso Health Group buyer in Q1 2022 was Citadel Advisors, an estimated $58.5K added.
  • The largest Akso Health Group seller in Q1 2022 was Renaissance Technologies, an estimated $164K sold.

Based on aggregated 13F filings for Q1 2022.